ANNOVIS BIO INC
ANVS·03615A108·US·Common Stock·Healthcare - Biotechnology-13D/G
ANVS (ANNOVIS BIO INC) is held by 31 institutional investors as of Q2 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), VANGUARD CAPITAL MANAGEMENT LLC ($3.1M), TUDOR INVESTMENT CORP ET AL ($2.5M). Net institutional sentiment: Mixed.
31
Holders
(3 Elite)
$14.7M
Total Value
61% (31)
Consensus
19 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders May 21, 2026 · Activists Aug 14, 2026 · Congress none
ActivistHIHighbridge Capital Management, LLC6.1%Aug 14, 2026
ActivistEAEmpery Asset Management, LP5.6%Jul 29, 2026
InsiderHBHoffman Michael BBuy $104KMay 20, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 37
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer